Publicacions en què col·labora amb Carmen Guillén Ponce (13)

2021

  1. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

    The Lancet Oncology, Vol. 22, Núm. 7, pp. 1014-1022

2020

  1. SEOM clinical guideline on hereditary colorectal cancer (2019)

    Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 201-212

2019

  1. Novel molecular characterization of colorectal primary tumors based on mirnas

    Cancers, Vol. 11, Núm. 3

2017

  1. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1618-1624

  2. Reduced risk of pancreatic cancer associated with asthma and nasal allergies

    Gut, Vol. 66, Núm. 2, pp. 314-322

2013

  1. EU pancreas: An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease

    Public Health Genomics, Vol. 16, Núm. 6, pp. 305-312

2010

  1. Biallelic MYH germline mutations as cause of Muir-Torre syndrome

    Familial Cancer, Vol. 9, Núm. 2, pp. 151-154

  2. Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: A pilot study

    Clinical and Translational Oncology, Vol. 12, Núm. 2, pp. 142-147

  3. EPCAM germ line deletions as causes of lynch syndrome in Spanish patients

    Journal of Molecular Diagnostics, Vol. 12, Núm. 6, pp. 765-770

  4. Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome

    Journal of Molecular Diagnostics, Vol. 12, Núm. 4, pp. 498-504

2009

  1. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: A case-control study

    BMC Cancer, Vol. 9

  2. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: A case-control study

    BMC Cancer, Vol. 9

  3. Utility of p16 immunohistochemistry for the identification of Lynch syndrome

    Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162